United States set
language
Menu Shopping cart $0 Search
Manufactured by BioVendor

Human Interleukin-17A ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, Biotin-labelled antibody
  • Other names:IL-17, Interleukin-17A
  • Species:Human
Cat. No. Size Price


RAF039R 96 wells (1 kit) $721,88
PubMed Product Details
Technical Data

Type

Sandwich ELISA, Biotin-labelled antibody

Description

The human IL-17A ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human IL-17A. The human IL-17A ELISA is for research use only. Not for diagnostic or therapeutic procedures.

Applications

Serum, Plasma-Heparin, Plasma-Citrate, Cell culture supernatant

Sample Requirements

50 µl/well

Shipping

On blue ice packs. Upon receipt, store the product at the temperature recommended below.

Storage/Expiration

Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

1.6–100 pg/ml

Limit of Detection

0.5 pg/ml

Intra-assay (Within-Run)

CV = 7.1%

Inter-assay (Run-to-Run)

CV = 9.1%

Spiking Recovery

serum 107.0%, heparin plasma 50.8%, citrate plasma 75,5%, cell culture supernatant 113.6%

Dilution Linearity

plasma 107.8%, cell culture supernatant 81.60%

Specificity

The interference of circulating factors of the immune systeme was evaluated by spiking these proteins at physiologically relevant concentrations into serum. There was no crossreactivity detected.

Summary

Features

  • RUO
  • calibration range 1.6-100 pg/ml
  • limit of detection 0.5 pg/ml
  • intra-assay CV = 7.1%
  • inter-assay CV = 9.1%

Research topic

Cytokines and chemokines and related molecules

Summary

A new family of cytokines, Interleukin-17, has recently been defined that reveals a distinct ligand-receptor signaling system. There is high evidence for its importance in the regulation of immune responses. IL-17A was first characterised and six IL-17 family members (IL-17A-F) have subsequently been described. IL-17A, a homodimeric cytokine of about 32 kDa, is largely produced by activated memory T lymphocytes, but stimulates innate immunity and host defense. IL-17A and IL-17F both mobilize neutrophils partly through granulopoeisis and CXC chemokine induction, as well as increased survival locally. IL-17A and IL-17F production by T lymphocytes is regulated by IL-23 independent of T cell receptor activation. The T help 1 (Th1) and Th2 cell classification has until recently provided the framework for understanding CD4(+) T cell biology and the interplay between innate and adaptive immunity. Recent studies have defined a previously unknown arm of the CD4(+) T cell effector response, the Th17 lineage. This subset of T cells produces interleukin 17, which is highly proinflammatory and induces severe autoimmunity. Whereas IL-23 serves to expand previously differentiated T(H)-17 cell populations, IL-6 and transforming growth factor-beta (TGF-beta) induce the differentiation of T(H)-17 cells from naive precursors. Increasing evidence shows that IL-17 family members play an active role in inflammatory diseases, autoimmune diseases, and cancer. The IL-17 signaling system is operative in disparate tissues such as articular cartilage, bone, meniscus, brain, hematopoietic tissue, kidney, lung, skin and intestine. Thus, the evolving IL-17 family of ligands and receptors may play an important role in the homeostasis of tissues in health and disease beyond the immune system. Increased levels of IL-17 have been associated with several conditions, including airway inflammation, rheumatoid arthritis, intraperitoneal abscesses and adhesions, inflammatory bowel disease,allograft rejection, psoriasis, cancer and multiple sclerosis.

Related Products Docs
Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
zavřít